DK1470829T3 - Poröst legeme med antibiotisk coating, fremgangsmåde til fremstilling samt anvendelse - Google Patents

Poröst legeme med antibiotisk coating, fremgangsmåde til fremstilling samt anvendelse

Info

Publication number
DK1470829T3
DK1470829T3 DK04007897T DK04007897T DK1470829T3 DK 1470829 T3 DK1470829 T3 DK 1470829T3 DK 04007897 T DK04007897 T DK 04007897T DK 04007897 T DK04007897 T DK 04007897T DK 1470829 T3 DK1470829 T3 DK 1470829T3
Authority
DK
Denmark
Prior art keywords
preparation
pore system
antibiotic
coating
porous body
Prior art date
Application number
DK04007897T
Other languages
Danish (da)
English (en)
Inventor
Sebastian Dr Vogt
Matthias Dr Schnabelrauch
Klaus-Dieter Dr Kuehn
Original Assignee
Heraeus Kulzer Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Heraeus Kulzer Gmbh filed Critical Heraeus Kulzer Gmbh
Application granted granted Critical
Publication of DK1470829T3 publication Critical patent/DK1470829T3/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/56Porous materials, e.g. foams or sponges
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/54Biologically active materials, e.g. therapeutic substances
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/20Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials
    • A61L2300/21Acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/404Biocides, antimicrobial agents, antiseptic agents
    • A61L2300/406Antibiotics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/45Mixtures of two or more drugs, e.g. synergistic mixtures
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/60Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a special physical form
    • A61L2300/606Coatings

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Transplantation (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Dermatology (AREA)
  • Biomedical Technology (AREA)
  • Dispersion Chemistry (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Oncology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Materials For Medical Uses (AREA)
  • Medicinal Preparation (AREA)
  • Saccharide Compounds (AREA)
  • Application Of Or Painting With Fluid Materials (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DK04007897T 2003-04-25 2004-04-01 Poröst legeme med antibiotisk coating, fremgangsmåde til fremstilling samt anvendelse DK1470829T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE10318991A DE10318991A1 (de) 2003-04-25 2003-04-25 Poröser Körper mit antibiotischer Beschichtung, Verfahren zur Herstellung sowie Verwendung

Publications (1)

Publication Number Publication Date
DK1470829T3 true DK1470829T3 (da) 2008-01-21

Family

ID=32946448

Family Applications (1)

Application Number Title Priority Date Filing Date
DK04007897T DK1470829T3 (da) 2003-04-25 2004-04-01 Poröst legeme med antibiotisk coating, fremgangsmåde til fremstilling samt anvendelse

Country Status (16)

Country Link
US (1) US20050031664A1 (el)
EP (1) EP1470829B1 (el)
JP (1) JP2004321804A (el)
CN (1) CN1569257A (el)
AT (1) ATE378077T1 (el)
AU (1) AU2004200955B2 (el)
BR (1) BRPI0401467A (el)
CA (1) CA2459619C (el)
CY (1) CY1108043T1 (el)
DE (2) DE10318991A1 (el)
DK (1) DK1470829T3 (el)
ES (1) ES2294388T3 (el)
PL (1) PL1470829T3 (el)
PT (1) PT1470829E (el)
SI (1) SI1470829T1 (el)
ZA (1) ZA200403113B (el)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040224981A1 (en) * 2003-05-01 2004-11-11 Nebojsa Janjic Antibacterial methods and compositions
DE102006016598A1 (de) * 2006-04-06 2007-11-15 Heraeus Kulzer Gmbh Beschichtete Vaskulärimplantate
DE102007039871A1 (de) * 2007-08-21 2009-02-26 Friedrich-Baur-Gmbh Weichgewebe-Implantat mit antibakterieller Wirkung
DE102010020940B4 (de) 2010-05-19 2014-09-25 Heraeus Medical Gmbh Antibiotische Beschichtung
DE102010055559B4 (de) 2010-12-23 2015-10-29 Heraeus Medical Gmbh Beschichtungsverfahren und Beschichtungsvorrichtung
DE102010055562B4 (de) 2010-12-23 2015-07-09 Heraeus Medical Gmbh Beschichtungsvorrichtung und Beschichtungsverfahren
DE102010055561B4 (de) 2010-12-23 2015-12-31 Heraeus Medical Gmbh Beschichtungsverfahren und Beschichtungsvorrichtung
DE102010055560B4 (de) 2010-12-23 2017-02-23 Heraeus Medical Gmbh Beschichtungsvorrichtung
DE102011117526B4 (de) 2011-11-03 2015-07-30 Heraeus Medical Gmbh Beschichtungsverfahren und Beschichtungsvorrichtung für medizinische Implantate

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3091572A (en) * 1962-07-16 1963-05-28 Schering Corp Gentamycin and method of production
FR1468638A (fr) * 1963-10-22 1967-02-10 Roussel Uclaf Sels de l'acide fusidique et procédé de préparation
DE2442021A1 (de) * 1974-09-03 1976-03-18 Bayer Ag Verfahren zur herstellung poroeser koerper auf der basis von gips, insbesondere anhydrit
US4291031A (en) * 1979-02-19 1981-09-22 Fujisawa Pharmaceutical Co., Ltd. 3-Phosphonocephalosporanic acid derivatives, and pharmaceutical composition comprising the same
GB2093348B (en) * 1981-02-23 1984-09-12 Leo Pharm Prod Ltd Pharmaceutical composition for implantation
DE3206725A1 (de) * 1981-05-13 1982-12-02 Merck Patent Gmbh, 6100 Darmstadt Schwer loesliche salze von aminoglykosidantibiotika
DE4314871A1 (de) * 1993-05-05 1994-11-10 Merck Patent Gmbh Lösungsmittel für ein schwerlösliches Gentamicin-Salz
DE19856668A1 (de) * 1998-12-09 2000-06-15 Aesculap Ag & Co Kg Wirkstoffmatrix in Form eines biologisch resorbierbaren porösen Vlieses, Verfahren zu ihrer Herstellung und Verwendung
DE10114245A1 (de) * 2001-03-22 2002-10-02 Heraeus Kulzer Gmbh & Co Kg Herstellung und Verwendung einer Antibiotikum-/Antibiotika-Zubereitung
DE10114364A1 (de) * 2001-03-22 2002-10-02 Heraeus Kulzer Gmbh & Co Kg Verfahren zur Herstellung von antibiotischen Kompositen
DE10114244A1 (de) * 2001-03-22 2002-10-02 Heraeus Kulzer Gmbh & Co Kg Antibiotikum-/Antibiotika-Zubereitung mit retardierender Wirkstofffreisetzung
DE10262176B4 (de) * 2002-06-21 2007-10-04 Heraeus Kulzer Gmbh Verfahren zur Herstellung von antibiotisch beschichteten porösen Körpern sowie Verwendung

Also Published As

Publication number Publication date
ZA200403113B (en) 2004-11-05
AU2004200955B2 (en) 2007-05-24
ES2294388T3 (es) 2008-04-01
BRPI0401467A (pt) 2005-01-18
DE502004005462D1 (de) 2007-12-27
SI1470829T1 (sl) 2008-04-30
CY1108043T1 (el) 2013-09-04
DE10318991A1 (de) 2004-11-18
JP2004321804A (ja) 2004-11-18
EP1470829B1 (de) 2007-11-14
PT1470829E (pt) 2007-12-26
US20050031664A1 (en) 2005-02-10
AU2004200955A1 (en) 2004-11-11
ATE378077T1 (de) 2007-11-15
PL1470829T3 (pl) 2008-06-30
EP1470829A1 (de) 2004-10-27
CN1569257A (zh) 2005-01-26
CA2459619A1 (en) 2004-10-25
CA2459619C (en) 2008-08-12

Similar Documents

Publication Publication Date Title
CY1108043T1 (el) Πορωδη σωματα με αντιβιοτικη επικαλυψη, μεθοδος παραγωγης και χρηση
ATE337802T1 (de) Poröse implantatkörper mit antibiotischer beschichtung, ihre herstellung sowie verwendung
WO2007062306A3 (en) Methods for coating surfaces with antimicrobial agents
WO2007050546A3 (en) Devices and methods for treating mitral valve regurgitation
NO20070695L (no) Fremgangsmate for substrat belegg med antimikrobisk virkemiddel og produkt dannet derav
CL2011000186A1 (es) Metodos para eliminar o prevenir el crecimiento de un microbio en un sustrato mediante la aplicacion de compuestos derivados de tetrakis (n-alquilpiridinio)- porfirina; composicion topica que comprende dicho compuesto; y metodo para prevenir y tratar una infeccion de la piel en un sujeto.
WO2008146368A1 (ja) 高耐食性希土類永久磁石の製造方法及び使用方法
TW200730248A (en) Palladium complex and catalyst-imparting treatment solution using the same
ATE389043T1 (de) Verfahren zur beschichtung eines substrates mit calciumphosphat
ATE539136T1 (de) Verkalkungsverfahren mit verkalkungsbakterien
WO2008070295A3 (en) System and method for the sonic-assisted cleaning of substrates utilizing a sonic-treated liquid
MX2016010864A (es) Metodo para el mantenimiento de cateteres uretrales.
ATE419225T1 (de) Verbundkeramikkörper sowie verfahren zum herstellen eines solchen
ATE253446T1 (de) Verfahren und vorrichtung zum aufbringen von selbstklebenden folienzuschnitten, insbesondere auf kfz-karosserieteile
DE602004026323D1 (de) Verbesserung der uberlebensfähigkeit von kryokonserviertem biologischem material nach dem auftauen durch provokation mit hydrostatischem druck
DE502004003920D1 (de) Verfahren zur Herstellung von wasserdispergierbaren Celluloseether mit vermindertem Glyoxalgehalt
ATE521504T1 (de) Verglasung
ATE283767T1 (de) Verfahren zur beschichtung eines bewegten trägers
NZ596492A (en) Redox drug derivatives
WO2009158179A3 (en) Applicator tool
WO2008056111A3 (en) Method and apparatus for treating a surface
WO2007118329A8 (en) Methods and agents for treating tuberculosis
CL2011001398A1 (es) Procedimiento para la preparacion de morfina-6-glucuronido o uno de sus derivados; compuesto derivado de morfina-6-glucuronido; utiles en el tratamiento del dolor de media y gran intensidad.
DE602006018167D1 (de) Verfahren zum konservieren von humanem zellmembranantigen
EP1666553A3 (de) Verfahren zum Aufbringen von Primern